Item 2.02. Results of Operations and Financial Condition.
On August 2, 2022, AtriCure, Inc. issued a press release regarding its financial
results for the second quarter ended June 30, 2022. The Company will hold a
conference call on August 2, 2022 at 4:30 p.m. Eastern Time to discuss the
financial results. A copy of the press release is furnished as Exhibit 99.1 to
this Form 8-K and is incorporated herein by reference.
Item 7.01. Regulation FD Disclosure.
During the week of August 2, 2022 the Company is holding meetings with investors
discussing, among other topics, an overview of the Company’s business and growth
strategy. A copy of the investor presentation, which is available at
http://www.atricure.com, is furnished as Exhibit 99.2 to this Form 8-K and is
incorporated herein by reference.
Information in the presentation contains forward-looking statements regarding
future events and performance of the Company. All such forward-looking
statements are based largely on the Company’s experience and perception of
current conditions, trends, expected future developments and other factors, and
on management’s expectations, and are subject to risks and uncertainties that
could cause actual results to differ materially, including, but not limited to,
those factors described in the presentation and in the Company’s filings with
the Securities and Exchange Commission. The Company disclaims any intention or
obligation to update or revise any financial or other projections or other
forward-looking statements, whether because of new information, future events or
The information in Item 2.02 of Form 8-K and in the press release attached as
Exhibit 99.1 and the presentation attached as Exhibit 99.2 is being furnished
and shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to
the liabilities of that Section. The information in each of Item 2.02 and Item
7.01 of this Form 8-K and Exhibit 99.1and Exhibit 99.2 shall not be incorporated
by reference in any filing or other document under the Securities Act of 1933,
as amended, or the Exchange Act, except as shall be expressly set forth by
specific reference in any such filing or document.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits No. Description Press Release dated August 2, 2022 relating to financial results for the second 99.1 quarter ended June 30, 2022 99.2 Investor Presentation Cover Page Interactive Data File--the cover page XBRL tags are embedded within 104 the Inline XBRL document.
© Edgar Online, source Glimpses